Dear FDA, Why now?


FDA Slaps Teva, Biogen With Enforcement Letters Over MS Drug Claims
fdanews.com
The FDA has zeroed in on misleading marketing of multiple sclerosis (MS) drugs, handing Teva and Biogen Idec enforcement letters for overstating efficacy and making unproven superiority claims.